Cargando…

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

BACKGROUND/PURPOSE: NGX-4010 (QUTENZA(™); NeurogesX Inc, San Mateo, CA), a capsaicin 8% dermal patch, is licensed in the European Union for the treatment of peripheral neuropathic pain (PNP) in nondiabetic adults and in the United States for the treatment of neuropathic pain associated with postherp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peppin, John F, Majors, Kristine, Webster, Lynn R, Simpson, David M, Tobias, Jeffrey K, Vanhove, Geertrui F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255992/ https://www.ncbi.nlm.nih.gov/pubmed/22247621 http://dx.doi.org/10.2147/JPR.S22954

Ejemplares similares

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain
por: Webster, Lynn R, et al.
Publicado: (2012)

Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia
por: Webster, Lynn R, et al.
Publicado: (2010)

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia
por: Webster, Lynn R, et al.
Publicado: (2011)

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials
por: Brown, Stephen, et al.
Publicado: (2013)

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)

Peripheral Neuropathic Pain Following Breast Cancer: Effectiveness and Tolerability of High-Concentration Capsaicin Patch
por: Dupoiron, Denis, et al.
Publicado: (2022)

Capsaicin 8% Patch and Chronic Postsurgical Neuropathic Pain
por: Giaccari, Luca Gregorio, et al.
Publicado: (2021)

Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain
por: Cruccu, G., et al.
Publicado: (2017)

Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
por: Huygen, Frank, et al.
Publicado: (2020)

Pain‐relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice
por: Hansson, P., et al.
Publicado: (2018)

Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland
por: Mankowski, Colette, et al.
Publicado: (2016)

Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study
por: Mankowski, Colette, et al.
Publicado: (2017)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014)

Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: A multicentre, randomized, assessor-blinded study
por: Jensen, TS, et al.
Publicado: (2014)

The Capsaicin 8% Patch for Neuropathic Pain in Clinical Practice: A Retrospective Analysis
por: Wagner, Till, et al.
Publicado: (2013)

Check Point NGX R65 Security Administration
por: Bonnell, Ralph
Publicado: (2008)

Compact quadrupole (MPS 4010-000-0)
por: Szeless, B
Publicado: (1973)

Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability
por: Laklouk, Muhammad, et al.
Publicado: (2016)

Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications
por: Freynhagen, Rainer, et al.
Publicado: (2021)

Vaccination Granuloma Itch Treated with Capsaicin 8% Patches
por: HOFFMANN, Stine, et al.
Publicado: (2020)

Configuring Check Point NGX VPN-1/FireWall-1
por: Stephens, Robert, et al.
Publicado: (2005)

Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups
por: Martini, Christian, et al.
Publicado: (2012)

High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience
por: Filipczak-Bryniarska, Iwona, et al.
Publicado: (2017)

Capsaicin 8% patch as therapy for neuropathic chronic postsurgical pain after melanoma excision surgery: A single center case series
por: Laude-Pagniez, Eulalie, et al.
Publicado: (2022)

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
por: Anand, P., et al.
Publicado: (2011)

Topical Capsaicin for the Treatment of Sensory Neuropathic Cough
por: Hoesli, Rebecca C., et al.
Publicado: (2021)

8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain
por: Light, Allison, et al.
Publicado: (2017)

Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study
por: Maihöfner, CG, et al.
Publicado: (2014)

Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification
por: Anand, Praveen, et al.
Publicado: (2019)

Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center
por: Bienfait, Florent, et al.
Publicado: (2023)

Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in Non-diabetic patients
por: Giménez-Milà, Marc, et al.
Publicado: (2014)

TG4010: A therapeutic vaccine against MUC1 expressing tumors
por: Limacher, Jean-Marc, et al.
Publicado: (2012)

NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer
por: Liu, Minji, et al.
Publicado: (2010)

Development of Capsaicin-Containing Analgesic Silicone-Based Transdermal Patches
por: László, Szabolcs, et al.
Publicado: (2022)

Capsaicin 8% patch reversibly reduces A-delta fiber evoked potential amplitudes
por: Papagianni, Aikaterini, et al.
Publicado: (2018)

Interest of a standardized hypnotic message for the reduction of pain and anxiety in cancer patients treated by capsaicin patch for neuropathic pain: a randomized controlled trial
por: Etienne, Rémi, et al.
Publicado: (2021)

Are We Ready to Recommend Capsaicin for Disorders Other Than Neuropathic Pain?
por: Silva, Janayne L., et al.
Publicado: (2023)

Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report
por: Sayanlar, Jennifer, et al.
Publicado: (2012)

Capsaicin 8% Patch Treatment in Non-Freezing Cold Injury: Evidence for Pain Relief and Nerve Regeneration
por: Anand, Praveen, et al.
Publicado: (2021)

Capsaicin-induced depolymerization of axonal microtubules mediates analgesia for trigeminal neuropathic pain
por: Arora, Vipin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0729abgl0bfrta94tjokuai3cq